Cargando…

Endothelin A Receptor Antagonism Enhances Inhibitory Effects of Anti-Ganglioside GD2 Monoclonal Antibody on Invasiveness and Viability of Human Osteosarcoma Cells

Endothelin-1 (ET-1)/endothelin A receptor (ETAR) signaling is important for osteosarcoma (OS) progression. Monoclonal antibodies (mAbs) targeting ganglioside GD2 reportedly inhibit tumor cell viability independent of the immune system. A recent study suggests that ganglioside GD2 may play an importa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Bo, Wu, Yi, Zhou, Yu, Peng, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984094/ https://www.ncbi.nlm.nih.gov/pubmed/24727660 http://dx.doi.org/10.1371/journal.pone.0093576

Ejemplares similares

Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside
por: Fleurence, Julien, et al.
Publicado: (2016)

GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody
Publicado: (1982)

Ganglioside GD2 expression is maintained upon recurrence in patients with osteosarcoma
por: Poon, Vincent I, et al.
Publicado: (2015)

A Monoclonal Antibody to O-Acetyl-GD2 Ganglioside and Not to GD2 Shows Potent Anti-Tumor Activity without Peripheral Nervous System Cross-Reactivity
por: Alvarez-Rueda, Nidia, et al.
Publicado: (2011)

Monoclonal antibody 3F8 recognises the neural cell adhesion molecule (NCAM) in addition to the ganglioside GD2.
por: Patel, K., et al.
Publicado: (1989)

Astrocyte elevated gene-1 regulates osteosarcoma cell invasion and chemoresistance via endothelin-1/endothelin A receptor signaling
por: LIU, BO, et al.
Publicado: (2013)

Acetylation Suppresses the Proapoptotic Activity of GD3 Ganglioside
por: Malisan, Florence, et al.
Publicado: (2002)

Biology of GD2 ganglioside: implications for cancer immunotherapy
por: Machy, Pierre, et al.
Publicado: (2023)

Expression of GD2 and GD3 gangliosides in human embryonic neural stem cells
por: Yanagisawa, Makoto, et al.
Publicado: (2011)

Ganglioside GD3 synthase (GD3S), a novel cancer drug target
por: Liu, Jinyi, et al.
Publicado: (2018)

Anti-ganglioside antibodies and celiac disease
por: Granito, Alessandro, et al.
Publicado: (2021)

Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy
por: Fleurence, Julien, et al.
Publicado: (2017)

The biological role and immunotherapy of gangliosides and GD3 synthase in cancers
por: Cao, Shangqi, et al.
Publicado: (2023)

GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer
por: Galan, Alba, et al.
Publicado: (2023)

Human melanoma antigen AH is an autoantigenic ganglioside related to GD2
Publicado: (1982)

Anti‐ganglioside GM(2) Monoclonal Antibody‐dependent Killing of Human Lung Cancer Cells by Lymphocytes and Monocytes
por: Hanibuchi, Masaki, et al.
Publicado: (1996)

Targeting GD2-positive Refractory/Resistant Neuroblastoma and Osteosarcoma with Anti- CD3 x Anti-GD2 Bispecific Antibody Armed T cells
por: Yankelevich, Maxim, et al.
Publicado: (2023)

Targeted Delivery of Immunotoxin by Antibody to Ganglioside GD3: A Novel Drug Delivery Route for Tumor Cells
por: Torres Demichelis, Vanina, et al.
Publicado: (2013)

Global Impact of Monoclonal Antibodies (mAbs) in Children: A Focus on Anti-GD2
por: Larrosa, Cristina, et al.
Publicado: (2023)

GD3- and O-acetylated GD3-gangliosides in the GM2 synthase-deficient mouse brain and their immunohistochemical localization
por: Matsuda, Junko, et al.
Publicado: (2006)

Longitudinal Evolution of the Concentration of Gangliosides GM3 and GD3 in Human Milk
por: Giuffrida, Francesca, et al.
Publicado: (2014)

Ganglioside GD2 in reception and transduction of cell death signal in tumor cells
por: Doronin, Igor I, et al.
Publicado: (2014)

RNA Sequencing-Based Identification of Ganglioside GD2-Positive Cancer Phenotype
por: Sorokin, Maxim, et al.
Publicado: (2020)

Ganglioside GD2 Enhances the Malignant Phenotypes of Melanoma Cells by Cooperating with Integrins
por: Yesmin, Farhana, et al.
Publicado: (2021)

Association of anti‐gangliosides antibodies and anti‐CMV antibodies in Guillain–Barré syndrome
por: Wang, Lijuan, et al.
Publicado: (2017)

Anti-Ganglioside Antibodies in Amyotrophic Lateral Sclerosis Revisited
por: Kollewe, Katja, et al.
Publicado: (2015)

Campylobacter jejuni Infection, Anti-Ganglioside Antibodies, and Neuropathy
por: Latov, Norman
Publicado: (2022)

Detection of anti-ganglioside antibodies in Guillain-Barré syndrome
por: Zhu, Wenli, et al.
Publicado: (2021)

Ganglioside GD2-specific trifunctional surrogate antibody Surek demonstrates therapeutic activity in a mouse melanoma model
por: Ruf, Peter, et al.
Publicado: (2012)

Upregulation of Ganglioside GD2 Synthase (GD2S), as a New Putative Cancer Stem Cell Marker in Breast Carcinomas
por: Mansoori, Maryam, et al.
Publicado: (2021)

Alterations in neuroblastoma ganglioside synthesis by induction of GD1b synthase by retinoic acid
por: Hettmer, S, et al.
Publicado: (2004)

Expression of ganglioside GD2, reprogram the lipid metabolism and EMT phenotype in bladder cancer
por: Vantaku, Venkatrao, et al.
Publicado: (2017)

The Effect of GD1a Ganglioside-Expressing Bacterial Strains on Murine Norovirus Infectivity
por: Zhu, Yifan, et al.
Publicado: (2020)

Ganglioside GD3 regulates neural stem cell quiescence and controls postnatal neurogenesis
por: Fuchigami, Takahiro, et al.
Publicado: (2023)

Novel anti-HER2 monoclonal antibodies: synergy and antagonism with tumor necrosis factor-α
por: Ceran, Ceyhan, et al.
Publicado: (2012)

Clinical Heterogeneity of Anti-GM2-Ganglioside-Antibody Syndrome
por: Kim, Jong Kuk, et al.
Publicado: (2018)

Are anti-ganglioside antibodies associated with proventricular dilatation disease in birds?
por: Leal de Araujo, Jeann, et al.
Publicado: (2017)

Disialyl GD2 ganglioside suppresses ICAM-1-mediated invasiveness in human breast cancer MDA-MB231 cells
por: Kwon, Kyung-Min, et al.
Publicado: (2017)

TWIST interacts with endothelin-1/endothelin A receptor signaling in osteosarcoma cell survival against cisplatin
por: ZHOU, YONG, et al.
Publicado: (2013)

Extracellular vesicles released from ganglioside GD2-expressing melanoma cells enhance the malignant properties of GD2-negative melanomas
por: Yesmin, Farhana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_79n78tj62ashugdvus7dpem74n